|
Sign In to gain access to subscriptions and/or personal tools.
|
Intravenous Anesthesia for the Patient with Left Ventricular Dysfunction
J. G. Bovill, MD, PhD
Department J.G. Bovill of Anaesthesiology, Leiden, University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands j.g.bovill{at}lumc.nl
Patients with heart failure have a diminished cardiac reserve capacity that may be further compromised by anesthesia. In addition to depression of sympathetic activity, most anaesthetics interfere with cardiovascular performance, either by a direct myocardial depression or by modifying cardiovascular control mechanisms. Etomidate causes the least cardiovascular depression. It is popular for induction of anesthesia in cardiac-compromised patients; however, it is not suitable for maintenance of anesthesia because it depresses adrenocortical function. Ketamine has a favorable cardiovascular profile related to central sympathetic stimulation and inhibition of neuronal catecholamine uptake. These counteract its direct negative inotropic effect. In patients with a failing myocardium, however, the negative inotropic effects may be unmasked, resulting in deterioration in cardiac performance and cardiovascular instability. Propofol is the most popular intravenous anesthetic for maintenance of anesthesia. It does have a negative inotropic effect, but the net effect on myocardial contractility is insignificant at clinical concentrations, probably because of a simultaneous increase in the sensitivity of the myofilaments to Ca2+. Propofol protects the myocardium against ischemiareperfusion injury, an action derived from its antioxidant and free-radical-scavenging properties as well as the related inhibition of the mitochondrial permeability transition pore. For intravenous anesthesia, propofol is always combined with an opioid. Opioids have relatively few cardiovascular side effects and, in particular, do not cause myocardial depression. Indeed, they are cardioprotective, with antiarrhythmic activity, and induce pharmacologic preconditioning of the myocardium by a mechanism similar to the inhalational anesthetics.
References
- Sprung J, Ogletree-Hughes ML, Moravec CS: The effects of etomidate on the contractility of failing and nonfailing human heart muscle. Anesth Analg 91:68-75, 2000.[Abstract/Free Full Text]
- Gelissen HP, Epema AH, Henning RH, et al: Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology 84:397-403, 1996.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Hert SG, Vermeyen KM, Adriaensen HF: Influence of thiopental, etomidate, and propofol on regional myocardial function in the normal and acute ischemic heart segment in dogs. Anesth Analg 70:600-607, 1990.[Abstract/Free Full Text]
- Riou B, Lecarpentier Y, Chemla D, Viars P: In vitro effects of etomidate on intrinsic myocardial contractility in the rat. Anesthesiology 72:330-340, 1990.[Web of Science][Medline]
[Order article via Infotrieve]
- Riou B, Lecarpentier Y, Viars P: Effects of etomidate on the cardiac papillary muscle of normal hamsters and those with cardiomyopathy. Anesthesiology 78:83-90, 1993.[Web of Science][Medline]
[Order article via Infotrieve]
- Sprung J, Schuetz S, Stewart RW, et al: Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro. Anesthesiology 88:1202-1210, 1998.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hanouz J-L, Persehaye E, Zhu L, et al: The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium: The effect of adrenoceptor blockade. Anesth Analg 99:1689-1695, 2004.[Abstract/Free Full Text]
- Kunst G, Martin E, Graf B, et al: Actions of ketamine and its isomers on contractility and calcium transients in human myocardium. Anesthesiology 90:1363-1371, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mullenheim J, Rulands R, Wietschorke T, et al: Late preconditioning is blocked by racemic ketamine, but not by S(+)-ketamine. Anesth Analg 93:265-270, 2001.[Abstract/Free Full Text]
- Hanouz JL, Zhu L, Persehaye E, et al: Ketamine preconditions isolated human right atrial myocardium: Roles of adenosine triphosphate-sensitive potassium channels and adrenoceptors. Anesthesiology 102:1190-1196, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chassot P-G, van der Linden P, Zaugg M, et al: Off-pump coronary artery bypass surgery: Physiology and anaesthetic management. Br J Anaesth 92:400-413, 2004.[Abstract/Free Full Text]
- Zheng D, Upton RN, Martinez AM: The contribution of the coronary concentrations of propofol to its cardiovascular effects in anesthetized sheep. Anesth Analg 96:1589-1597, 2003.[Abstract/Free Full Text]
- Bilotta F, Fiorani L, La Rosa I, et al: Cardiovascular effects of intravenous propofol administered at two infusion rates: A transthoracic echocardiographic study. Anaesthesia 56:266-271, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nakae Y, Fujita S, Namiki A: Propofol inhibits Ca2+ transients but not contraction in intact beating guinea pig hearts. Anesth Analg 90:1286-1292, 2000.[Abstract/Free Full Text]
- Sprung J, Ogletree-Hughes ML, McConnell BK, et al: The effects of propofol on the contractility of failing and nonfailing human heart muscles. Anesth Analg 93:550-559, 2001.[Abstract/Free Full Text]
- Kanaya N, Murray PA, Damron DS: Propofol increases myofilament Ca2+ sensitivity and intracellular pH via activation of Na+-H+ exchange in rat ventricular myocytes. Anesthesiology 94:1096-1104, 2001.[Web of Science][Medline]
[Order article via Infotrieve]
- Gable BD, Shiga T, Murray PA, Damron DS: Propofol increases contractility during a1a-adrenoreceptor activation in adult rat cardiomyocytes. Anesthesiology 103:335-343, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mather LE, Duke CC, Ladd LA, et al: Direct cardiac effects of coronary site-directed thiopental and its enantiomers: A comparison to propofol in conscious sheep. Anesthesiology 101:354-364, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Weaver BM, Staddon GE, Mapleson WW: Tissue/blood and tissue/water partition coefficients for propofol in sheep. Br J Anaesth 86:693-703, 2001.[Abstract/Free Full Text]
- Upton RN, Huang YF, Grant C, et al: Myocardial pharmacokinetics of thiopental in sheep after short-term administration: Relationship to thiopental-induced reductions in myocardial contractility. J Pharm Sci 85:863-867, 1996.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ouattara A, Langeron O, Souktani R, et al: Myocardial and coronary effects of propofol in rabbits with compensated cardiac hypertrophy. Anesthesiology 95:699-707, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Riou B, Besse S, Lecarpentier Y, Viars P: In vitro effects of propofol on rat myocardium. Anesthesiology 76:609-616, 1992.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Riou B, Lejay M, Lecarpentier Y, Viars P: Myocardial effects of propofol in hamsters with hypertrophic cardiomyopathy. Anesthesiology 82:566-573, 1995.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hebbar L, Dorman BH, Clair MJ, et al: Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure. Anesthesiology 86:649-659, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lowe D, Hettrick, Douglas A, et al: Propofol alters left ventricular afterload as evaluated by aortic input impedance in dogs. Anesthesiology 84:368-376,1996.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pagel PS, Hetrick DA, Kersten JR, et al: Cardiovascular effects of propofol in dogs with dilated cardiomyopathy. Anesthesiology 88:180-189, 1998.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gare M, Parail A, Milosavljevic D, et al: Conscious sedation with midazolam or propofol does not alter left ventricular diastolic performance in patients with preexisting diastolic dysfunction: A transmitral and tissue Doppler transthoracic echocardiography study. Anesth Analg 93:865-871, 2001.[Abstract/Free Full Text]
- Zaugg M, Lucchinetti E, Uecker M, et al: Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 91:551-565, 2003.[Abstract/Free Full Text]
- Zaugg M, Lucchinetti E, Garcia C, et al: Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth 91:566-576, 2003.[Abstract/Free Full Text]
- Zaugg M, Schaub MC, Foex P: Myocardial injury and its prevention in the perioperative setting. Br J Anaesth 93:21-23, 2004.[Free Full Text]
- Xia Z, Godin DV, Ansley DM: Propofol enhances ischemic tolerance of middle-aged rat hearts: Effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 59:113-121, 2003.[Abstract/Free Full Text]
- Lim KH, Halestrap AP, Angelini GD, Suleiman MS: Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood) 230:413-420, 2005.[Abstract/Free Full Text]
- Kokita N, Hara A, Abiko Y, et al: Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 86:252-258, 1998.[Abstract]
- Yoo KY, Yang SY, Lee J, et al: Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth 82:90-96, 1999.[Abstract/Free Full Text]
- Mathur S, Farhangkhgoee P, Karmazyn M: Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: Role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Anesthesiology 91:1349-1360, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kawano T, Oshita S, Tsutsumi Y, et al: Clinically relevant concentrations of propofol have no effect on adenosine triphosphate-sensitive potassium channels in rat ventricular myocytes. Anesthesiology 96:1472-1477, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kawano T, Oshita S, Takahashi A, et al: Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 100:338-346, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kevin LG, Novalija E, Stowe DF: Reactive oxygen species as mediators of cardiac injury and protection: The relevance to anesthesia practice. Anesth Analg 101:1275-1287, 2005.[Abstract/Free Full Text]
- Eriksson O, Pollesello P, Saris N-EL: Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anaesthetic propofol. Biochem Pharmacol 44:391-393, 1992.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Murphy PG, Myers DS, Davies MJ, et al: The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 68:613-618, 1992.[Abstract/Free Full Text]
- Kahraman S, Demiryurek AT: Propofol is a peroxynitrite scavenger. Anesth Analg 84:1127-1229, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kokita N, Hara A: Propofol attenuates hydrogen peroxideinduced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 84:117-127, 1996.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Javadov SA, Lim KHH, Kerr PM, et al: Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45:360-369, 2000.[Abstract/Free Full Text]
- Kowaltowski AJ, Castilho RF, Vercesi AE: Mitochondrial permeability transition and oxidative stress. FEBS Lett 20;495:12-15, 2001.
- Halestrap AP, Clarke SJ, Javadov SA: Mitochondrial permeability transition pore opening during myocardial reperfusion and its inhibition in cardioprotection. Cardiovasc Res 61:372-385, 2004.[Abstract/Free Full Text]
- Hausenloy DJ, Duchen MR, Yellon DM: Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 1;60:617-625, 2003.
- Shanmuganathan S, Hausenloy DJ, Duchen MR, et al: Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289:H237-H242, 2005.[Abstract/Free Full Text]
- Hausenloy DJ, Yellon DM, Mani-Babu S, et al: Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 287:H841-H849, 2004.[Abstract/Free Full Text]
- Feng J, Lucchinetti E, Ahuja P, et al: Isoflurane preconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3b. Anesthesiology 103:987-995, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Javadov SA, Clarke S, Das M, et al: Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549(Pt 2):513-524, 2003.[Abstract/Free Full Text]
- Xiao G-S, Zhou J-J, Wang G-Y, et al: In vitro electrophysiologic effects of morphine in rabbit ventricular myocytes. Anesthesiology 103:280-286, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hung CF, Tsai CH, Su MJ: Opioid receptor independent effects of morphine on membrane currents in single cardiac myocytes. Br J Anaesth 81:925-931, 1998.[Abstract/Free Full Text]
- Yvon A, Hanouz JL, Terrien X, et al: Electrophysiological effects of morphine in an in vitro model of the border zone between normal and ischaemic-reperfused guinea-pig myocardium. Br J Anaesth 89:888-895, 2002.[Abstract/Free Full Text]
- Schultz JE, Gross GJ: Opioids and cardioprotection. Pharmacol Ther 89:123-137, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sigg DC, Coles JA, Gallagher WJ, et al: Opioid preconditioning: Myocardial function and energy metabolism. Ann Thorac Surg 72:1576-1582, 2001.[Abstract/Free Full Text]
- Zhang Y, Irwin MG, Wong TM: Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 101:918-923, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart Circ Res 78:1100-1114, 1996.
- Fryer RM, Hsu AK, Nagase H, Gross GJ: Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels. Circ Res 84:846-851, 1999.[Abstract/Free Full Text]
- Liang BT, Gross GJ: Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 25; 84:1396-1400, 1999.
- Ludwig LM, Patel HH, Gross GJ, et al: Morphine enhances pharmacological preconditioning by isoflurane: Role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 98:705-711, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sigg DC, Coles JA, Oeltgen PR, Laizzo PA: Role of delta opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol 282:H1953-H1960, 2002.[Abstract/Free Full Text]
- Schultz JE, Hsu AK, Gross GJ: Ischemic preconditioning in the intact rat heart is mediated by delta1-but not muor kappa-opioid receptors. Circulation 7;97:1282-1289, 1998.
- Kato R, Ross S, Foex P: Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 84:204-214, 2000.[Abstract/Free Full Text]
- Fryer RM, Wang Y, Hsu AK, Gross GJ: Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280:H1346-H1353, 2001.[Abstract/Free Full Text]
- Kato R, Foex P: Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats. Br J Anaesth 84:608-614, 2000.[Abstract/Free Full Text]
- Frassdorf J, Weber NC, Obal D, et al: Morphine induces late cardioprotection in rat hearts in vivo: The involvement of opioid receptors and nuclear transcription factor kB. Anesth Analg 101:934-941, 2005.[Abstract/Free Full Text]
Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 10, No. 1,
43-48 (2006)
DOI: 10.1177/108925320601000108

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K.-X. Liu, S.-Q. Chen, W.-Q. Huang, Y.-S. Li, M. G. Irwin, and Z. Xia
Propofol Pretreatment Reduces Ceramide Production and Attenuates Intestinal Mucosal Apoptosis Induced by Intestinal Ischemia/Reperfusion in Rats
Anesth. Analg.,
December 1, 2008;
107(6):
1884 - 1891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. ten Brinke, R. J. Klautz, S. A. Tulner, F. H. Engbers, H. F. Verwey, D. E. Atsma, M. J. Schalij, E. E. van der Wall, J. J. Bax, H. Putter, et al.
Haemodynamics and left ventricular function in heart failure patients: Comparison of awake versus intra-operative conditions
Eur J Heart Fail,
May 1, 2008;
10(5):
467 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Williams, B. M. Philip, L. F. Chu, M. G. Boltz, K. Kamra, H. Terwey, G. B. Hammer, S. B. Perry, J. A. Feinstein, and C. Ramamoorthy
Ketamine Does Not Increase Pulmonary Vascular Resistance in Children with Pulmonary Hypertension Undergoing Sevoflurane Anesthesia and Spontaneous Ventilation
Anesth. Analg.,
December 1, 2007;
105(6):
1578 - 1584.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|